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Abstract
Human infection by malarial parasites of the genus Plasmodium begins with the bite of an infected Anopheles mosquito.
Current estimates place malaria mortality at over 650,000 individuals each year, mostly in African children. Efforts to reduce
disease burden can benefit from the development of mathematical models of disease transmission. To date, however,
comprehensive modeling of the parameters defining human infectivity to mosquitoes has remained elusive. Here, we
describe a mechanistic within-host model of Plasmodium falciparum infection in humans and pathogen transmission to the
mosquito vector. Our model incorporates the entire parasite lifecycle, including the intra-erythrocytic asexual forms
responsible for disease, the onset of symptoms, the development and maturation of intra-erythrocytic gametocytes that are
transmissible to Anopheles mosquitoes, and human-to-mosquito infectivity. These model components were parameterized
from malaria therapy data and other studies to simulate individual infections, and the ensemble of outputs was found to
reproduce the full range of patient responses to infection. Using this model, we assessed human infectivity over the course
of untreated infections and examined the effects in relation to transmission intensity, expressed by the basic reproduction
number R0 (defined as the number of secondary cases produced by a single typical infection in a completely susceptible
population). Our studies predict that net human-to-mosquito infectivity from a single non-immune individual is on average
equal to 32 fully infectious days. This estimate of mean infectivity is equivalent to calculating the human component of
malarial R0. We also predict that mean daily infectivity exceeds five percent for approximately 138 days. The mechanistic
framework described herein, made available as stand-alone software, will enable investigators to conduct detailed studies
into theories of malaria control, including the effects of drug treatment and drug resistance on transmission.
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Introduction
Approximately 2.5 billion people live in areas whose local
epidemiology permits transmission of Plasmodium falciparum, the
parasite that causes the most life-threatening form of malaria [1].
Malaria has inflicted a severe toll in morbidity and mortality over
the course of human history. Nonetheless, recent studies, however,
document significant reductions in malaria mortality over the past
decade [2,3]. Given these encouraging results, public health
experts are planning campaigns to reduce or eliminate transmis-
sion from many areas of the world [4,5]. To help assess the
feasibility of eliminating malaria from an area, efforts are ongoing
to model and map the historical and current limits of this
transmission. These models and maps also help establish a baseline
to judge the success of these efforts [1,6,7]. The development of
these mathematical frameworks, however, is complicated by the
diversity of mosquito vectors, varying levels of human immunity,
and the extent to which control efforts are applied.
The development of mathematical models of malaria is
contingent on a detailed understanding of the parasite lifecycle.
This begins in humans when motile parasite forms, termed
sporozoites, enter the body through the bite of an Anopheles
mosquito and travel to the liver where they rapidly proliferate.
Upon emerging from the liver, parasites then enter the blood
stream as merozoites. These merozoites infect red blood cells
(RBCs), develop, replicate, burst from the infected cells, and repeat
the cycle of asexual blood stage infection that causes disease. These
asexual blood stages are able to avoid clearance in the spleen by
expressing surface ligands that enable parasitized red blood cells
(PRBCs) to adhere to endothelial cells in the microvasculature
[8,9]. This property of cytoadherence and sequestration results
from surface expression of P. falciparum erythrocyte membrane
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protein (PfEMP1). Because PfEMP1 presents a prominent
antigenic target for the immune system, P. falciparum has evolved
a sophisticated system of epigenetically-regulated antigenic vari-
ation, whereby individual parasites typically express only a single,
antigenically-distinct member of the multigene family var that
encodes PfEMP1 [8,9]. Expression continuously switches between
var genes as a mechanism to continually present new epitopes that
escape an already existing antibody response. Separate from the
pathogenic asexual blood stages, intra-erythrocytic parasites can
also differentiate into sexual stages known as gametocytes [10].
Once parasites have committed to becoming gametocytes, they
sequester in the bone marrow or microvasculature and develop
through four stages for 7–12 days [11]. They then reenter the
circulation to complete their maturation as Stage V gametocytes.
Mature Stage V male and female gametocytes are then primed to
form gametes and mate in the midgut of the definitive host, the
Anopheles mosquito, following blood meal ingestion.
Many models of malaria have been developed to describe this
cycle of transmission from the mosquito to the human host and
back. These models can be broadly classified into two categories:
compartmental and mechanistic. A compartmental model is any
type of transmission model that simulates populations of individ-
uals transitioning into different compartments at constant rates,
with each compartment representing a different state of disease/
non-disease. For example, an ‘‘SIR’’ model is a compartmental
model in which individuals are grouped into three populations,
namely susceptible (S), infectious (I), and recovered (R). Individuals
transition between compartments at a constant rate depending on
several factors that include the virulence of the disease and the
immune responses of hosts. More sophisticated models include
additional compartments that each represent a different disease
state. For example, the infective compartment may be separated
into multiple compartments (I1, I2, I3, etc.) each with different
levels of infectiousness, or other compartments may be added, for
example infected but not infectious hosts (known as the E
compartment) [12]. The basic units of analysis in compartmental
models are populations; the number of individuals within each
disease state is tracked over time, but individuals are categorized
only to the extent that they occupy one of the various
compartments.
In contrast, mechanistic malaria models incorporate the within-
host mechanisms that determine human infectiousness over time.
In such models, individual hosts are the primary units of analysis
[13,14]. Transitioning among different levels of infectivity occurs
because of individual clearance of infections, and parasite densities
are modeled at the individual level. Individuals differ in multiple
parameters including the intensity and duration of infection and
the timing of fever.
Each of these two frameworks has a useful role to play.
Compartmental models benefit from simplicity, identifiably, and
clarity, while mechanistic ones allow for simulations of control
measures that are highly non-linear. Regardless of the model type,
one of the most important mathematical quantities for theories of
disease control aimed at elimination is R0, the basic reproduction
number [15]. R0 is defined as the number of secondary cases that
an index case would generate in a population without previous
exposure to the disease. R0 serves as a threshold criterion for
transmission: if the R0 of an area is below 1, the disease will
eventually become extinct; if above 1, the disease will spread. For
malaria, R0 can be expressed as the product of the vectorial
capacity (the number of infectious mosquito bites that result from
mosquitoes taking blood meals on a fully infectious human in a
single day), the duration of the human infectious period, and the
efficiency of transmission from humans to mosquitoes.
Vectorial capacity can be estimated using a variety of
techniques [7,16–22]. However, the human component of malaria
transmission is difficult to quantify, in part, because the
transmissibility of an infection is affected by many competing
factors. Although a variety of mathematical models have been
built to simulate the progression of malaria infections, [13,23–27],
no model has yet produced an estimate of net human infectivity
over time.
Here, we report a stochastic, mechanistic, within-host model
that simulates the progression of Plasmodium falciparum infections
and human-to-mosquito infectivity. We built upon previously
published work by Molineaux and Dietz, who first developed the
asexual and gametocyte components of our model from malaria
therapy data, in which individuals with tertiary syphilis were
infected with P. falciparum to induce a fever and clear the syphilitic
bacteria [23–25]. This framework has been used to simulate the
effects of vaccines on transmission [13,23–26]. However, this
earlier work required that parameters be fitted to an individual
patient’s case history before simulation. We have extended these
earlier studies by choosing stochastic distributions for model
parameters, thereby allowing for within-host simulations that
generate an ensemble of infection dynamics that are consistent
with observed malaria therapy infections. We also included
additional components that enable simulations of human-to-
mosquito infectivity and onset of symptoms.
Using this model, we have examined the levels of human-to-
mosquito infectivity over time and isolated the host-related
determinants of the basic reproduction number, R0. This novel
analysis of R0 made it possible to analyze overlooked aspects of
transmission relevant for elimination campaigns. We calculated
that net human infectivity is equivalent to 32 fully infectious days,
on average. Further, we calculated the distribution of infectious-
ness within human populations given the natural variability of
individuals’ immune responses to infection, as well as the mean
infectivity of a population over time. We found that infectiousness
from malaria persists for a long duration of time: mean
infectiousness is predicted to exceed five percent for 138 days
after infection. These results were then compared to outputs from
Author Summary
We report a new mathematical model of the progression,
within a human host, of a malaria infection caused by the
parasite Plasmodium falciparum. This model incorporates
probability distributions for the key parameters of infec-
tion and transmission so that model outputs match the
entire range of observed responses in patients, without
the requirement for fitting individual data. Further, we
simulate the daily densities of both the disease-causing
and transmissible forms of the parasite within an individ-
ual, as well as the onset of fever and the probability of
parasite transmission to mosquitoes. This model allows us
to reproduce aspects of infection that are critical for
malaria control modeling. As a first application, we
calculate the net infectiousness of humans to mosquitoes
and predict that net human infectivity from a single
infection is on average equal to approximately 32 fully
infectious days. This value has been used to help map the
worldwide intensity of malaria transmission. We also
predict that mean daily infectivity is greater than five
percent for approximately 138 days. Our modeling
framework, available as downloadable software, will allow
researchers to probe the effects of treatment and drug
resistance on malaria transmission in unprecedented
detail, helping to improve malaria control efforts.
A Mechanistic Model of Malarial Infectiousness
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compartmental models [12,28,29]. We propose that the modeling
work described herein provides the most careful estimate yet of the
distribution of human responses to malaria infection and the mean
human contribution to R0. Our model also provides a framework
to examine how antimalarials may affect malaria transmission,
given the complexities of host-parasite dynamics.
Methods
Defining a model of asexual parasitemia
The model used to calculate asexual parasitemia is a within-host
model that simulates the course of an infection one replication cycle
after merozoites have emerged from the liver. Asexual parasitemias
are modeled as a system of discrete (two-day time interval)
difference equations previously elaborated by Molineaux et al.
[13,23]. The model simulates parasite densities in 50 different
subpopulations differentiated by var gene expression type. In each
replication cycle, a fixed percentage of parasites in each subpop-
ulation switch into a different population. The switching probabil-
ities are structured such that certain var genes are expressed with
higher probability than others; immune pressure against variants
also plays a role (the switching phenomenon is described below).
Asexual parasitemia densities are regulated by three host immune
responses: an innate response that establishes an upper limit for
parasite density; a PfEMP1 variant-specific response that regulates
short-term periodic oscillations in density; and a variant-transcend-
ing response that causes a steady log-linear decrease in density over
time, clearing the infection. We do not simulate deaths from
malaria, as these are so few in proportion to the very large number
of total infections as to not significantly impact overall transmission.
Our model was fitted to data from malaria therapy patients, in
which individuals with tertiary syphilis and with no acquired
immunity to malaria were inoculated with single strains of P.
falciparum in order to induce a fever and clear the infection [30,31]
(see details below). Thus, our asexuals model best reproduces the
time course of asexual parasitemias in malaria-naı¨ve adult male
patients who exhibited effective immune responses.
1. Quantities modeled.
Pi tð Þ: The number of red blood cells infected by Plasmodium
falciparum parasites displaying PfEMP1 type i at time t
PC tð Þ: The cumulative number of number of red blood cells
infected at time t
2. Constants and parameters.
s: Proportion of isotype population that switches var expression
in each period; constant
v: Number of PfEMP1 variants (set to 50); constant
M: Minimum parasitemia simulated by model; constant
pi tð Þ: Probability that isotype population Pj will switch into
population Pi; variable, see description below in section on
antigenic variation
3. Equations determining asexual parasitemia.





miSC tð ÞSi tð ÞSm tð Þ
Pi tz2ð Þ~ Pi tz2ð Þ
0 if Pi tz2ð Þ0§M






Host immune response parameters
Our within-host model incorporates three types of immune
responses. An innate response SC tð Þ represents inflammation,
fever, and cytokine responses to parasite replication and is a
function of total parasite load, irrespective of PfEMP1 type. The
two other immune responses are acquired and are dependent on
antibody production. Si tð Þ represents the PfEMP1 variant-specific
immune response, with the response to each isotype denoted by
the subscript i. Sm tð Þ represents the acquired PfEMP1 variant-
transcending immune response. This immune response is
provoked by the conserved regions of PfEMP1 (since some
PfEMP1 variants have been shown to induce cross-reactivity) as
well as conserved surface proteins (such as MSP-1) and other
parasite antigens. Both of the antibody responses are assumed to
decay exponentially over time in the absence of new antigen
production in our model.
Each of these three responses has a characteristic effect on the
progression of parasitemia. The innate response controls the initial
densities of asexual parasitemia and is dominant during the initial
period of infection. The second response, the variant-specific acquired
response, controls the characteristic peaks and dips in parasitemia and
interacts with the var switching structure to determine the densities of
PfEMP1 variants over time. The third response is the variant-
transcending acquired response, which produces the roughly log-linear
decline in parasitemias over time and helps to clear the infection. We
assumed that the strengths of the innate and variant-transcending
immune responses vary among individuals.
1. Quantities modeled.
SC tð Þ: The innate immune response
Si tð Þ: The PfEMP1 variant-specific acquired response
Sm tð Þ: The PfEMP1 variant-transcending acquired immune
response
2. Constants and parameters.
PC : Determines the parasite density at which the innate
immune response reaches 50% of maximum; stochastic (see below)
Pm: Determines the parasite density at which the PfEMP1
variant-transcending immune response reaches 50% of maximum;
stochastic (see below)
Pv : Determines the parasite density at which the PfEMP1
variant-specific immune response reaches 50% of maximum;
constant
kC: Determines functional form (Hill slope) of innate immune
response to total parasitemia; constant
km: Determines functional form (Hill slope) of variant-tran-
scending immune response to cross-reactive epitopes; constant
kv: Determines functional form (Hill slope) of variant-specific
immune response to individual PfEMP1 variants; constant
s: Decay rate of acquired immune response to PfEMP1 variant;
constant
dv: Delay in onset of acquired immune response to PfEMP1
variant; constant
t: Index variable used to sum over previous asexual parasitemia
levels
b: Affects levels of acquired variant-transcending immune
response; constant
dm: Delay in onset of variant-transcending acquired immune
response; constant
r: Decay rate of variant-transcending acquired immune
response; constant
C: Level of parasitemia above which variant-transcending
immunity does not increase; constant
PC
kC
: Asexual parasite density at the first peak of parasitemia (the
maximum asexual parasitemia); stochastic following a truncated
A Mechanistic Model of Malarial Infectiousness
PLOS Computational Biology | www.ploscompbiol.org 3 April 2013 | Volume 9 | Issue 4 | e1003025
log-normal distribution with a mean of 104.79 parasites per mL (this
was the median among malaria therapy patients from [23]) and a
scale parameter of 1.148 (from [32])
Pm
km
: First asexual parasitemia observation day minus the last
asexual parasitemia observation day; stochastic following a
Gompertz distribution (as reported in [33]) with shape parameters
(0.0311, 0.0004) chosen to fit the malaria therapy data from Sama
et al. [33]
3. Equations determining host immune functions.
























PC tð Þ if PC tð ÞƒC
C if PC tð ÞwC
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Antigenic variation
In our model, PfEMP1 variant densities are explicitly modeled.
The parasite population is partitioned into 50 different subpop-
ulations, each representing one antigenic isotype (i ). The
probability that a given isotype population Pj will switch into the
population Pi is given by the probability pi(t), which changes over
time (and is independent of j ). The probability pi(t) is designed to
incorporate three aspects of var switching leading to expression of
the antigenically distinct PfEMP1 proteins.
First, we assume that the PfEMP1 status of parasites is reset
during the mosquito stage such that infections start with a single
PfEMP1 variant [34]. Second, we assume that the probability of
switching into variants is not constant among the variants, but is
structured such the likelihood of switching into some variants is
greater than the likelihood for others [34–36]. This pattern may
reflect the distance of the var genes from the telomeric regions or
other types of inherent var structure and gene regulation [34–36].
Third, we assume that a PfEMP1 variant has a decreased
probability of appearing if the immune system has previously
mounted a response to that variant. The biological rationale for
this assumption is that a prior immune response will decrease the
probability of a variant appearing because parasites expressing this
variant are more likely to be cleared before reaching densities
detectable by smear.
It is also possible that more than one variant, even most or all
variants, are expressed at the onset of infection [37,38]. However,
the innate response controls the initial phase of infection (before
antibodies are developed), and this response is independent of the
PfEMP1 types present. During this early period of infection, there
is likely to be selective pressure from the host against some
isotypes, such that some isotypes are eliminated [38]. Thus, even if
all variants are expressed initially, only some will survive to the
period when antibodies are formed. The difference between a
model in which all variants are expressed initially and our model is
that the former relies entirely on variant cross-reactivity and/or
immunodominance to maintain infections [39,40], whereas ours
relies on both cross-reactivity and the appearance of less likely
variants to maintain infections.
In our model, we also assume that parasites expressing different
PfEMP1 variants proliferate at different rates. We assign each isotype a
growth rate mi chosen from a truncated normal distribution. This
assumption is based on experimental evidence that some PfEMP1
variants proliferate faster than others in vivo (specifically, some variants
that are associated with severe disease have been shown to propagate
faster than those that are not) [41]. Further, certain variants may be
better adapted to a host’s particular biology than others, resulting in
differences in net growth rates in vivo [38].
1. Quantities modeled.
pi tð Þ: Probability that a PRBC will switch to the ith PfEMP1
isotype at time t+2; units are in probability of switching per two
days
2. Constants and parameters.
q: Parameter for geometric distribution affecting isotype-
dependent switching probability; constant (set to 0.3)




m: Parameters for normal distribution describing isotype-
specific growth rates; constant
3. Equations describing PfEMP1 dynamics.
pi tð Þ~




if Si tð Þ§I
8>><
>>:





truncated so that 1#mi#35
Modeling the onset of first fever
Because we are interested in utilizing this model to simulate
drug treatment in low-transmission areas, treatment-seeking
behavior is an important consideration. In the absence of
diagnostic testing, fever may serve as an indicator of infection
for both patient and clinician [42,43]. To predict when fever first
occurs, we utilize modeling by Dietz et al. [44] who used malaria
therapy data to fit probability distributions to the onset of fever. In
our model, all patients are assumed to be symptomatic and to
experience a fever that begins a variable number of days before
reaching maximum parasitemia. To determine the day of first
fever following one cycle of replication after emergence of
parasites from the liver into the blood stream (taken as time zero),
we use a uniform distribution based on an individual’s maximum
asexual parasitemia [13,44].
Specifically, we simulate the time course of an individual
infection from inoculation to clearance and record the maximum
parasitemia achieved (denoted PM ). We then take a random draw
(denoted d) from the distribution U(log10(0.0002), 0) =U(23.699,
0) and calculate Pf~10
d :PM [13,44]. The first day that an
individual’s parasitemia is greater than or equal to Pf is assumed
to be the first day of fever for that individual.
1. Quantities modeled.
feverday: The predicted first fever day of an individual, set to the
first day that an individual’s asexual parasitemia is greater than or
equal to Pf ; variable, depends on individual simulation
Pf : Fever threshold; variable, depends on individual simulation
A Mechanistic Model of Malarial Infectiousness
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2. Constants and parameters.
F: Lower limit of uniform distribution determining fever
threshold; constant (set to 0.0002)
PM : Maximum level of asexual parasitemia; variable, depends
on individual simulation
3. Equations determining first fever.
Pf~PM :10
U log10 Fð Þ,0ð Þ, where U(a, b) is a draw from the uniform
distribution with lower bound a and upper bound b
Modeling gametocyte densities over time
Our gametocytemia model equations were first articulated by
Diebner et al. and Eichner et al. (the two models differ slightly; we
adhere to the formulation by Eichner et al.) [24,25]. In our model
gametocytes are produced by each wave of asexual parasitemia at a
stochastic frequency determined by the function c(). Gametocytes are
assumed to sequester for a variable number of days as they develop.
Once the mature gametocytes emerge into the blood stream, they are
cleared by the immune system, die naturally, or are transmitted to a
mosquito. Our gametocyte model simulates levels of circulating (Stage
V) gametocytes as well as numbers of gametocytes in the earlier stages
(Stages I–IV) on a daily timescale. Gametocyte lifetimes, in the absence
of immune response related to asexual parasitemia, are assumed to
follow a Gompertz distribution [24]. We assume that the degree of
anti-gametocyte immunity is related to the cumulative levels of
previous asexual parasitemia. We do not include any suppressive effect
of fever on gametocyte densities, as reported in [45].
As in the asexual model described above, the original gametocyte
modeling work [24,25] fitted model parameters to each individual
patient’s malaria therapy data. We modified their model by choosing
model parameters from probability distributions such that the resulting
outputs matched the observed variability in the malaria therapy data.
1. Quantities modeled.
G(t): The number of mature gametocytes circulating in the
bloodstream. Gametocyte gender is not modeled (see section on
infectivity below).
2. Constants and parameters.
DS: Sequestration time for gametocyte maturation in days;
stochastic with truncated normal distribution (m= 7; s= 1.5); the
truncation interval is set so that DS[ 4,12½ 
c: Asexual to sexual conversion probability, peak specific;
stochastic following log-normal distribution with location param-
eter of 26 and a scale parameter of 4 in natural log space
aG: Rate at which age affects gametocyte mortality; stochastic
with uniform distribution between .06 and 1
b: Effects of previous levels of asexual parasitemias on
gametocyte death rates; constant
m0: Initial age-related component of total gametocyte mortality
rate; constant
t: Index variable used to sum over gametocyte ages (in number
of days old)














ln PC sð Þz1ð Þ
 
Human-to-mosquito infectivity parameters
In the original Ross-Macdonald model, the infectivity of
humans to mosquitoes was parameterized by a constant, c [46].
In our model we estimate the probability of human-to-mosquito
transmission (defined as production of an oocyst [47]) as a function
of gametocyte levels. For our baseline simulations, we utilize the
nonlinear relationship between gametocytemia and infectivity
described by Stepniewska et al. based on mosquito feeding studies
on malaria therapy patients [47–49]. Net infectivity for an
individual is quantified by taking the area under a curve generated
from predicted infectivity over time; this quantity is equivalent to
the number of fully infectious days.
Our model of infectivity is not mechanistic in the same way
that our asexual and gametocyte models are. We use the
sigmoidal curve reported in [48] to force high gametocyte
densities to be substantially less infectious than would be
predicted by a proportional model of infectivity. We do not
model why this nonlinearity occurs. Two main hypotheses could
explain the reduced infectivity of gametocytes at high densities.
The first is that gametocytes themselves regulate their infectious-
ness in a density-dependent manner [50–53] such that high
densities are proportionally much less infectious than low
densities. The second hypothesis is that host factors (antibodies,
cytokines, fever) affect the infectivity of gametocytes [27,54–57],
though fever was not found to influence the infectivity of
gametocytes in malaria therapy [58]. In our model, we do not
include these possible additional factors in the calculation of
human-to-mosquito infectivity; however, we did conduct a
sensitivity analysis to examine the effects of different density-to-
infectivity relationships on our model outputs.
A final note regarding infectivity is that of Jeffery and Eyles in
their original 1955 study of mosquito feedings on malaria therapy
patients [47]. These authors observed that, in the first two to four
days after gametocytes were observable in the bloodstream of
infected patients, individuals were not infectious to mosquitoes.
They attributed this phenomenon to the fact that, when
gametocytes are first becoming microscopically detectable, they
are immature and are thus unable to infect mosquitoes. We
account for the observed non-infectivity of gametocytes appearing
very early in the course of infection by adjusting modeled
infectivity profiles slightly. Specifically, if the difference between
the first observable asexual and sexual parasitemias was 15 days or
less for a simulated individual, then this individual becomes
infectious two days after gametocytes were first observed. For
individuals with larger differences between asexual and gameto-
cyte patency, or that never have an observable gametocytemia, we
assume that individuals are not infectious until more than 17 days
after asexual blood stage parasites are first detectable. This
adjustment roughly corresponds to the feeding study data reported
by Jeffery and Eyles [47].
1. Quantities modeled.
c(x): The infectivity of humans to mosquitoes (i.e. the percent
chance that a mosquito blood meal will result in oocysts in the
mosquito midgut), where x is the gametocyte density per mL.
2. Constants and parameters.
mintrans: Minimum gametocyte density that allows for transmission
3. Equations determining gametocyte infectivity.
c xð Þ~1:08:e{e{0:86 log10 xð Þ{1:48ð Þ .
The functional relationship between gametocyte density and
infectivity used here is taken from [48]. Note that c(x) is set to 0 for a
variable period during the onset of gametocyte appearance (as
reported in [47]). Our default model also assumes that infectivity is 0
if gametocyte density is below 2/3 gametocytes per mL, due to the
need for 2 gametocytes to be present per blood feed (assuming 3 mL
of blood per feed); we call this threshold mintrans. We vary these
assumptions in the sensitivity analysis.
A Mechanistic Model of Malarial Infectiousness
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Fitting our model to malaria therapy data
Prior information on parameter distributions. In the
initial formulation upon which we built our asexuals model [23],
two parameters (infection duration and maximum density) were
fitted to individual patient case histories. To develop our
mechanistic model, we found distributions from the published
literature to inform our choice of both parameters. For the
duration of infection model parameter, a study found that the
durations of infection in malaria therapy were Gompertz
distributed with a mean duration of patent parasitemia of 210.7
days [33]. For the distribution of maximum parasitemias, a
previous within-host model parameterized to malaria therapy data
used a log-normal distribution [32]. For the mean of this
distribution, we used the median (104.79 asexual parasites per
mL) observed among 35 malaria therapy patients [23]; to set an
upper bound, we used the maximum observed parasitemia (105.66
asexual parasites per mL) from [23].
In the original formulation of our gametocyte model, five
parameters were fitted to individual patient case histories [24,25].
After a literature review we found data that determined two of the
five distributions. Eichner et al. reported that the sequestration
delay DS roughly followed a normal distribution [25] with a mean
of 7.4 days. Eichner et al. also reported that g, the average asexual-
sexual conversion probability, roughly followed a lognormal
distribution with a mean of 0.0064; this information informed
our choice of c, the asexual-sexual model conversion distribution.
The other three gametocyte model parameters (aG, b, and m0) had
insufficient information to determine their distributions.
Fitting asexual parasitemias and gametocyte
densities. The first component that we fitted to data was the
asexuals model. For our simulation target data, we used the
distribution of durations of infection from malaria therapy [59] as
well as the minimum, median, and maximum of 9 clinical
indicators from malaria therapy data. These malariometric indices
were derived by Molineaux et al. from 35 malaria therapy patient
charts [23]. We note that these 35 charts were selected from a total
of 334 patients because this subset was classified as ‘spontaneous
cures’ given their treatment history (although some of the 35 did
receive low-dose suppressive treatments). Note also that we defined
a ‘local maxima’ in asexual parasitemia as a parasitemia a) greater
than the 6 values preceding it and b) greater or equal to the 6
values following [23].
With the target data defined, we then fitted the model to these
data. For a measure of the goodness-of-fit, we used the relative
errors between model outputs and the min, median, and max of
the 9 indices, as well as the distances between the modeled and
observed durations of infection (as measured from the cumulative
distribution functions). We used the log-normal distribution for
maximum parasitemias with a mean of 104.79 asexual parasites per
mL to set PC , which determines the parasite density at which the
innate response reaches 50% of maximum [23,32]. To fit the
duration of infectivity and the min, med, and max of the nine
indices from malaria therapy, we varied kC, which determines the
relationship between asexual density and level of innate immune
response, s, the decay rate of the variant-specific response, and
Pm, which determines the parasite density at which the variant-
transcending response reaches 50% of maximum. We also
truncated the isotype-specific growth rates mi to have a maximum
value of 35 [23]. Choosing these four parameters to fit to data
allowed us to decrease the overall model degrees of freedom but
still have control over all three types of immune response.
To fit the gametocyte model parameters we first needed to
define our target data. We used DS, the average duration of
gametocyte sequestration, g, the average asexual to sexual parasite
conversion probability, and L, the average length of time that
gametocytes are observed in the circulation, as our target indices.
These indices were derived for the malaria therapy data by
Eichner et al. [25]. For a measure of the goodness-of-fit, we used
the differences between the geometric mean, minimum, and
maximum values from malaria therapy and model outputs. When
calculating gametocyte densities from asexual parasitemias we
assumed that asexual parasitemias were local maxima only if they
satisfied the two criteria above as well as were c) greater than or
equal to 100 PRBC/mL (as in [25]).
We had three gametocyte model parameters to fit for which we
had insufficient prior information: aG, b, and m0. As for the asexual
model, there were too many degrees of freedom to test model
outputs against malaria therapy data using all possible combina-
tions of model parameters. We used the reported quantiles for
these three parameters from Diebner et al. [24] to help inform our
choice of initial values. After experimenting with model outputs,
assuming a variety of different distributions for the parameters, we
found that we could reproduce the range of observed variation
with b and m0 being fixed at their population means (as reported in
[24]) and aG varying according to a uniform distribution. Table 1
provides the best-fit values and distributions for these asexual and
gametocyte model parameters; parameters that are not listed in
Table 1 remain unchanged from their previously published values
[23–25].
Assessing the goodness-of-fit. We first consider the good-
ness-of-fit of the asexual component of the model. Table 2
compares the minima, medians, and maxima of the malaria
therapy data to bootstrapped values from the model outputs using
the best-fit parameters. From this table, we see that the geometric
means of the temporal intervals between local maxima are shorter
in the model than observed in the data (Table 2, index 2–5). In
other words, the ‘peaks’ of asexual parasitemia occur closer
together in the model than in the data (though the total number of
peaks in the model and the data are approximately the same). This
difference may indicate that some var switching rates need to be
reduced in our model, or that shared epitopes among variants
repress densities for longer in vivo than in the current model.
Further, the model slightly overestimates the mean proportion of
positive observations in both halves of patency, indicating that the
model predicts that infections are more often observable during
their duration of patency than are observed clinically (Table 2,
indices 2-7, 2-8). The model also overestimates the variability of
the height of the peaks associated with PfEMP1 variants (Table 2,
index 2-6). The model does fit data quite well for density at first
maximum, as well as last positive day, with very low relative errors
for those indices (Table 2, indices 2-2, 2-9).
For the gametocyte model, we were able to set the delay of
appearance parameter DS directly given prior information [25],
and so there is little error between modeled and observed mean,
minimum, and maximum values. For the observed average
asexual-to-sexual conversion probability g, this is driven mostly
by the parameter c, and so we were also able to match the
observed variation with little absolute error (Table 3). The
average length of time that gametocytes are circulating in the
bloodstream (index L) is controlled in the model by the immune
parameters aG, b, and m0. By setting b and m0 to their population
means and allowing aG to vary uniformly between 0 and 1, we
could generate the entire range of malaria therapy variation.
However, having individuals with average gametocyte circulation
times of 22 days yielded a model that was difficult to reconcile with
other data sets [60]. We thus set aG,U(0.06, 1) such that the
maximum average gametocyte circulation time was set to be
approximately 14 days (Table 3).
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Of note, we did not explore the entire parameter space for the
asexual and gametocyte models, given computational limitations.
Our final parameters were chosen as best-fits when the model
outputs were qualitatively judged to be acceptably close according
to the goodness-of-fit described above. We thus cannot provide
precise point estimates with confidence intervals for our param-
eters. Nevertheless, sensitivity analyses were performed for certain
parameters, as described below.
As a further check of our model outputs, we also compared our
model outputs to other data not explicitly used in the model fitting.
The modeled arithmetic mean duration of time between first fever
and first gametocytemia detectable by smear among gametocyte-
positive individuals was ,12.9 days. This compares closely to the
measured value from malaria therapy patients (10–11) [45]. Also,
Jeffery and Eyles in their original 1955 study of mosquito feedings
on malaria therapy patients reported that gametocytes generally
become observable 10–15 days after parasite patency [47]. We
found similar values (mode,11 days; median,11 days), although
the model also generated larger values (,20% of gametocyte
positive individuals had differences between the first day of asexual
patency and the first day of gametocyte patency $20 days).
Results
Development of a mechanistic model of within-host
malarial infection
We have developed a mechanistic model of the progression of
malaria within a human host, parameterized such that the model
reproduces the median and extremes of the dynamics of infection
observed in malaria therapy. For the asexuals model, we fitted five
model parameters to the minimum, medians, and maxima of nine
different malariometric indices derived from malaria therapy data.
For the gametocyte model, we fitted five model parameters to the
minima, geometric means, and maxima of three different indices
derived from the gametocytemias of malaria therapy patients.
Table 1 illustrates those model parameters that were changed
from published reports. A mathematical formulation of the model,
as well as a description of how it was fitted to data, is described in
the Methods. Standalone versions of the model for Macintosh or
PC platforms are provided in the Supporting Information (see
MACmodel.zip and PCmodel.zip), along with user manuals (Text S1)
and an illustration of the graphical user interface (Figure S1).
Figure 1 graphically illustrates the important features of our
model by presenting three individual simulations. Figure 1A
illustrates the P. falciparum lifecycle for reference. Figure 1B shows
simulated asexual parasite densities over time, expressed as log10
PRBC per mL of blood. The black line illustrates the lower limit of
detectability by microscopy (10 PRBC/mL) [45,61]. The individ-
ual depicted in green has patent parasitemias for a period of ,50
days, lapses into sub-patent parasitemia for ,60 days, then has a
short period of patency before relapsing permanently into sub-
patent parasitemias. The infection is completely cleared by ,day
400, post emergence of parasites from the liver. The characteristic
peaks and dips apparent in the densities are associated with
PfEMP1-based antigenic variation. The individual in purple
displays three separate periods of patent parasitemia, whereas
the individual in blue also has four periods, with the first lasting
nearly 100 days. The inset in Figure 1B shows the first 50 days of
infection along with the first fever day for each individual (onsets of
fever are indicated by triangles). Fever is simulated to occur on day
7 post emergence for the individual depicted in green, day 11 for
the blue individual, and day 12 for the purple.
Figure 1C shows the daily gametocytemias of the simulated
individuals from Figure 1B. Note that the x-axis scale has been
reduced from 700 to 600 for clarity. For the green individual,
,10% of the first wave of asexual parasites converts to
Table 1. Best-fit model parameter constants and distributions.
Model Parameter Reference value Revised value/distribution3 Description
Asexual kc 0.2
1 0.164 Affects levels of innate immune
response to total parasitemia
Asexual s 0.021 0.15 Decay rate of acquired immune
response to PfEMP1 variant
Asexual Pc*/kc Fitted to case history
1 truncated lnN(m,s2), m= ln(104.79),
s=1.148, truncation point = 5.5
Asexual parasite density at the first peak
of parasitemia
Asexual Pm*/km Fitted to case history
1 Gompertz(a,h), a= 0.0311, h=0.0004 First day with observed asexual
parasitemia minus last observed day
Asexual mi truncated N(m,s
2), m=16,
s=10.4, truncation point = 11
truncated N(m,s2), m=16, s= 10.4,
truncation points = 1, 35
Growth rates of different PfEMP1
variants
Gametocyte Ds Fitted to case history
2 round(truncated N(m,s2)), m= 7, s= 1.5,
truncation points = 4, 12
Sequestration time for gametocyte
maturation
Gametocyte c Fitted to case history 2 truncated lnN(m,s2), m=26, s= 4,
truncation point = 0.189
Asexual to sexual conversion
probability, peak specific
Gametocyte aG Fitted to case history
2 U(0.06,1) Rate at which age affects gametocyte
mortality
Gametocyte b Fitted to case history 2 0.0013 Effects of previous asexual parasitemias
on gametocyte death rates
Gametocyte m0 Fitted to case history




3The best-fit parameters for the asexual and gametocyte components of our mechanistic model are shown for those parameters that have been modified from their
original values [23,24]. All other model parameters not provided above remain equal to their values in [23,24]. ‘Fitted to case history’ indicates that the model was run
with this parameter as a free parameter and the best-fit value was chosen after fitting outputs to the case history of an individual treated using malaria therapy.
doi:10.1371/journal.pcbi.1003025.t001
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Table 3. Comparison of gametocyte model outputs to malaria therapy data.
DS g L
Malaria
therapy1 Simulated2 Malaria therapy Simulated
Malaria
therapy Simulated
Minimum 4.0 4.0 2.7 E-04 6.5 E-05 1.3 3.2
Geometric Mean 7.4 6.9 0.0064 0.0066 6.4 5.6
Maximum 12.0 10.8 0.135 0.111 22.2 13.9
1See ref [25]. Three properties of within-host gametocyte dynamics were imputed from malaria therapy data. The properties are DS, the gametocyte sequestration time
in days; g, the average gametocyte conversion probability; and L, the length of time gametocytes persist in circulation. The first column for each parameter lists the
value from 113 malaria therapy patients [25].
2Gametocyte properties were calculated from the mechanistic malaria model outputs using best-fit gametocytemic parameters. Model values are from 50 samples of
113 runs each, from a total of 1,000 runs. The end time for all runs was 800 days.
doi:10.1371/journal.pcbi.1003025.t003
Figure 1. Illustration of asexual, sexual, and infectivity outputs. Our mechanistic P. falciparum infection model was used to simulate three
individuals’ host-parasite dynamics. (A) Schematic representation of the P. falciparum life cycle. The parasite is transmitted to humans though the bite
of an infected mosquito. Motile forms (sporozoites) travel to the liver where they proliferate as liver stage parasites that and are then released into the
blood. Parasites then adopt ,48 hr cycles of red blood cell (RBC) invasion, asexual blood stage replication, and egress. Some intra-erythrocytic
parasites differentiate into sexual forms (gametocytes) for uptake by further mosquito bites. Asexual parasites avoid immune capture by antigenic
variation, primarily PfEMP1 cycling. (B) Individual log10 asexual parasitemias presented as a function of the number of days post emergence of
parasites from the liver into the bloodstream. The inset depicts the first 50 days of infection; triangles above indicate the first day of fever. The black
line is the level of detectability by microscopy (10 parasitized red blood cells (PRBC)/mL). (C) Daily gametocytemias of the same three individuals. (D)
Estimated probability of human-to-mosquito transmission. Areas under the infectivity curves are equivalent to the number of fully infectious days.
Although the model predicts the persistence of long-lived low-level and sub-detectable infections (as observed in malaria therapy), this panel
illustrates how the bulk of infectivity usually occurs early in the course of infection.
doi:10.1371/journal.pcbi.1003025.g001
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gametocytes. However, the later waves of asexual parasitemia have
much lower asexual-to-sexual conversion probabilities, resulting in
sub-patent gametocytemias after ,day 60 and essentially no
gametocytes after day 340. The asexual-to-sexual conversion
probability is chosen stochastically for each wave of asexual
parasitemia for each individual according to the distribution
observed from malaria therapy (the geometric mean probability of
conversion is approximately 0.7%). For the blue individual, the
first asexual wave has a lower conversion probability than the
second, resulting two gametocyte peaks of roughly equal height;
gametocytes disappear from microscopic detection near day 140
and are completely cleared by day 600. For the purple individual,
conversion probabilities are so low that gametocytes are patent
only for a very short period between days 20 and 40 post
emergence and are cleared completely near day 400.
Figure 1D illustrates the daily probabilities of human-to-
mosquito transmission (i.e. the probabilities that a mosquito bite
on these individuals would produce oocysts). The x-axis scale is
now reduced from 600 to 250 days. To calculate the infectivity
curves in Figure 1D, the gametocyte densities in Figure 1C were
transformed using a sigmoidal relationship derived from feeding
studies on malaria therapy volunteers [48] (see section below on
gametocyte densities and their relationship to human-to-mosquito
infectivity). Net infectivity is calculated by integrating the daily
human-to-mosquito infectivity curves over time (shaded areas).
The peaks of patent gametocytemia for the green, blue, and purple
individuals in Figure 1C are clearly mirrored in Figure 1D,
though the peaks of infectivity are exaggerated due to the
transformation from density to infectivity.
Assumptions concerning antigenic variation
As illustrated in Figure 1, an important feature of within-host
malaria dynamics is antigenic variation. This variation is governed
to a considerable extent by the nature of var gene switching leading
to the expression of antigenically distinct PfEMP1 variants. In our
model, we assumed that var is reset during infection so that only
one variant is expressed after emergence from the liver. We then
assumed that a fixed percentage of parasites switch into a new var
type per replication cycle, with certain var variants more likely to
appear than others. Further, we assumed that immune pressure
against a given variant would reduce its likelihood of appearing.
Figure 2 illustrates the var (PfEMP1) expression patterns for a
representative simulated individual. Figure 2A decomposes the
total parasitemia over time into the various var subpopulations,
such that each color corresponds to the proportion of parasitemia
for each given type. Individual var types are counted as expressed
only if their corresponding parasite populations reach 0.02
parasites per microliter, the assumed threshold for detection by
polymerase chain reaction [62]. Figure 2B shows the total
number of var variants expressed at any given time post
emergence, and Figure 2C shows the cumulative number of var
variants that have been expressed during the course of the
infection (some variants are removed by the immune response).
This particular simulation has a maximum of 10 variants
simultaneously expressed within the first few days of infection,
and this level decreases over time because of immune clearance.
Because the switch rates for some variants are assumed to be faster
than others (following a geometric series with a common ratio of
1/3), simulations exhibit a substantial var variation early in the
infection, with only a few less-favored variants appearing later.
Figure 2D illustrates the total parasitemia over time, which is
affected not only by the var switch rate but also by the three types
of host immune response (innate, variant-specific, and variant-
transcending).
Figure 2. Illustration of model var dynamics. The members of the
PfEMP1 family of P. falciparum erythrocyte membrane proteins are
encoded by var genes, present at ,60 copies per genome and each
expressing a different PfEMP1 type. (A) Total asexual parasitemia as a
function of time post emergence from the liver was modeled and the
proportion filled by each PfEMP1 variant is shown in a different color.
The number of colors and their respective levels at a given time
indicates the diversity of isotypes present. Results are shown from a
single model output. (B) The number of isotypes circulating in the
blood over time. Isotypes are ‘expressed’ only if the density of that
isotype is greater than or equal to 0.02 parasitized red blood cells
(PRBC) per mL (the assumed threshold for PCR detection). (C) The
cumulative number of isotypes that have been expressed over time
(modeled from a single infection). (D) Levels of total asexual parasitemia
over time for the illustrated run, in log10 PRBC per mL.
doi:10.1371/journal.pcbi.1003025.g002
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Relationships between gametocyte density and parasite
infectivity to mosquitoes
Another important determinant of human infectivity is the
assumed relationship between gametocyte density and parasite
infectivity to mosquitoes (also referred to as human-to-mosquito
infectivity). A variety of functions relating gametocytes to
infectivity have been described and proposed in the literature
[48,56,63,64]. All of these relationships share two features: a)
infectivity increases monotonically with density, and b) high
gametocyte densities are proportionally less infectious than low
densities. However, the exact shapes of the curves differ. For our
best-fit parameterization, we relied upon the functional form fitted
by Stepniewska et al. [48] from human feeding studies conducted
from malaria therapy patient volunteers. Figure 3 illustrates this
sigmoidal relationship (in red, denoted ‘Median Infectivity, Stage
V’), as well as a scatterplot of density versus infectivity data from
Carter and Graves [63,64] (blue circles) and from a meta-analysis
by Bousema et al. [56] (purple squares).
Goodness-of-fit of modeled durations of asexual
infection and gametocyte densities
Figure 4 provides a graphical illustration of two measures of
model fit using the best-fit parameters. Figure 4A illustrates a
measure of goodness-of-fit for our asexuals model, specifically the
cumulative distributions of the durations of infection for both our
model and the malaria therapy data [33]. The grey horizontal line
illustrates the median durations of infection: our within-host model
has a slightly shorter median duration (196 days) than the malaria
therapy data (215 days) [33]. The slope of the cumulative
distribution function from our model outputs is slightly steeper
than that from the malaria therapy, indicating less variation in our
modeled durations of infectivity compared to the malaria therapy
data. However, the maximum durations of infectivity between
model and malaria therapy are very similar. Figure 4A also shows
the cumulative durations predicted by the two other models (in
pink and green; see below).
For our model of gametocyte densities, we visually examined a
total of 262 malaria therapy charts provided by Diebner et al.
[24,65] and recorded the maximum observed gametocytemia from
each patient (data were recorded as log10 values to the nearest
tenth). We then compared these data to the maximum gametocy-
temias from 1,000 runs of our model using the best-fit parameters.
Because the Diebner et al. study only includes individuals who
recorded at least four gametocyte-positive observations [24], we
censored out model runs in which gametocyte levels never exceeded
10 per mL, leaving 988 runs remaining.
Figure 3. Relationships between gametocyte density and probability of human-to-mosquito infectivity. The scatterplot data (blue
circles) were collated by Carter and Graves from multiple studies [63,64]. The blue line is a logistic regression through the Carter and Graves data. The
Bousema data indicate the relationship between infectivity and density from skin feeding studies with predominantly African volunteers in endemic
settings [56]. The red line indicates the infectivity of malaria therapy volunteers (‘Median Infectivity, Stage V’) [48]; this parameterization is assumed to
be the default. The red dotted lines illustrate the ‘High’ (maximum) and ‘Low’ (minimum) infectivity curves used in the model. The light blue solid and
dotted lines indicate the relationships between gametocyte density and infectivity, assuming only Stage VB gametocytes are infectious (see
Methods). All infectivity relationships included in the model are truncated at 1 (i.e. 100% probability of infection).
doi:10.1371/journal.pcbi.1003025.g003
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Figure 4B provides the empirical cumulative distributions of
the durations of gametocytemia for the two data sets after log-
transformation, i.e., the proportion of data that are less than or equal
to a given level of log10 gametocytemia. The malaria therapy values
are slightly higher on average initially, with a median of 3.10 for
malaria therapy versus 2.95 from the model (grey horizontal line).
Our model had a broader tail than the malaria therapy data, with
more elevated gametocytemias than observed in the therapy data.
The mean from the malaria therapy data was 3.01, whereas the mean
from the model was 2.98. However, in our model, we estimated
gametocytemias every day (i.e., we captured every maximum
possible), as opposed to the sparser sampling of the malaria therapy
data. Further, some of the individuals included in the patient charts
from [24] were treated with chloroquine, chlorguanide, or quinine to
terminate the infection after the initial period of continuous patent
asexual parasitemia [23]. This treatment may have slightly biased
downward the recorded malaria therapy maxima.
Classical description of host contributions to R0
Once we were able to generate malarial infections in silico that
resembled malaria therapy data across a variety of indices, we then
attempted to quantify the distribution of human infectivity over
time. The basic reproduction number R0 is one of the most
important parameters for quantifying the infectivity of a disease
[15]. The classical expression for the R0 of malaria was derived by
Macdonald and can be formulated with four terms [46,66,67].
Potential transmission by a mosquito population is described by its
vectorial capacity, V0, which describes the number of infectious bites
that would arise from all the mosquitoes that bite one fully infectious
individual on a single day. Two parameters, b and c, describe the
proportion of blood meals that successfully cause an infection: b is
the probability that an infected mosquito will infect an uninfected
human upon biting; c is the probability than an infected human will
infect an uninfected mosquito during a blood meal. In the Ross-
Macdonald model, the infectious period of humans is exponentially
distributed, with a daily clearance rate of r and a mean duration of
infection of r21 days. The basic reproduction number of malaria is




The Ross-Macdonald model [46,66,67] assumes that c is a constant
over this period, so the ratio c/r describes the net infectiousness of a
simple human infection. This net infectiousness fraction can be
interpreted as the number of days that a person is fully infectious.
Mean human infectivity over time
In reality, neither V0, b, c, nor r are constant among individuals
over time and R0 is only the first moment of a complicated
multivariate distribution. Consider a population of N individuals,
none of whom have been previously exposed to malaria. These
individuals will differ in their responses to malarial infection,
including onset of first fever relative to the initiation of blood stage
infection, immune responses to asexual and sexual parasite densities
over time, and the time to clearance of infection. We let Di(t) denote
the probability that individual i will infect a mosquito upon being
bitten at time t; this function takes values between 0 and 1. With our
mechanistic model, one can simulate the full variability of Di(t) for
populations with no acquired immunity.







Figure 4. Comparison of model and malaria therapy cumula-
tive distributions for two indices. (A) These line curves show the
cumulative distributions of the durations of infection for the malaria
therapy data, as well as those of our mechanistic model and the
compartmental models of Lawpoolsri et al. [29] and Okell et al. [12]. The
distribution from the malaria therapy data comes from fitting a
Gompertz probability distribution to the durations of infection from 54
patients, as reported by Sama et al. [33]. The cumulative distribution
function of the best-fit Gompertz distribution is plotted in red. The
mechanistic model cumulative distribution was generated by calculat-
ing the durations of infection for 1,000 runs and plotting their empirical
cumulative distribution function. The distributions from Lawpoolsri et
al. and Okell et al. were generated by running those compartmental
models according to their mathematical assumptions. The malaria
therapy and mechanistic model distributions show relatively tight fits
throughout the distribution. The durations of infections for the malaria
therapy data and our mechanistic model are defined as the last
observable day by smear minus the first observable day; the durations
for the compartmental models are defined as the durations of time in
infectious compartments. (B) We reviewed a total of 262 malaria
therapy charts and recorded the maximum observed gametocytemia
from each patient (data were recorded as log10 values to the nearest
tenth) [24,65]. We then recorded the maximum gametocytemias from
1,000 runs of our model. Because the malaria therapy data only include
individuals who recorded at least four positive gametocyte observa-
tions, we censored out model runs in which gametocyte levels never
exceeded 10 per mL (N = 988) [24]. Illustrated are the empirical
cumulative distributions for the two data sets after log-transformation,
i.e., the proportion of data that are less than or equal to a given level of
log10 gametocytemia.
doi:10.1371/journal.pcbi.1003025.g004
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the resulting function D(t) is a function of time only. We call this
function the mean human infectivity over time. Mean human
infectivity is an important function for elimination in many
contexts. Calculation of D(t) allows for a determination of how
likely malaria will be able to persist through droughts or intensive
antimalarial campaigns. The function D(t) for our mechanistic
model is shown in Figure 5 under best-fit model parameters. In
Figure 5A, the simulated asexual parasitemias from 1,000 runs of
the model are illustrated. A large diversity in responses can be
observed, with asexual parasitemias differing among individuals by
many orders of magnitude post emergence. These differences in
asexual parasitemias are also mirrored in large differences among
individuals in both gametocyte densities and human-to-mosquito
infectivity over time (not shown). Figure 5B illustrates the 25th
and 75th percentiles of daily infectivity for these simulated
individuals, as well as the mean infectivity over time (in red).
The mean infectivity D(t) is skewed due to the presence of some
individuals exhibiting long-lived infectious periods. One important
prediction from our model is that mean infectiousness is greater
than five percent for 138 days after infection (see Discussion).






We call Di the distribution of net infectivity within a population.
This distribution describes how individuals vary in infectiousness
given the natural variability in host-parasite interactions. Our
model-predicted Di is shown as a violin plot in Figure 5C. The
infectivity of most individuals is clustered around the mean value
(32 fully infectious days); however, there are an appreciable
number of individuals who are predicted to be much more
infectious than the mean individual. The maximum observed
infectivity is 125.2 fully infectious days.
If we integrate either the mean human infectivity over time D(t)
with respect to t, or the distribution of net infectivity Di over a
population, we arrive at what we call the mean net human
infectivity, D. The quantity D was first described in the supplement
to [1]; this malaria map made use of preliminary results from the









For our mechanistic model D ranges between approximately 31–
34 when averaged over a population of 1,000 individuals (the
mean of 5,000 runs was 32.4). The units of D can be considered as
fully infectious days, i.e., the number of days in which an
individual has a probability of 1 of infecting a mosquito. This value
represents the human contribution to R0, and we note here that D
is invariant across time, space and ecological setting.
Comparison of infectivity over time and net infectivity
among malaria models
Once we had computed Di, D(t), and D, we then compared our
calculations to values imputed from three other models: those of
Lawpoolsri et al. [29], Okell et al. [12], or Dietz et al. (known as
the ‘Garki model’) [28]. The former two models were designed to
simulate the effectiveness of antimalarials at reducing malaria
transmission and are the focus of our comparisons. The model of
Lawpoolsri et al. was fitted to data from a low-transmission region
of Thailand (PfPR,0.0–1.5) [29] while the model of Okell et al.
was fitted to three regions of medium intensity transmission in
Tanzania. Both are compartmental models (Lawpoolsri et al. has
one infectious compartment and Okell et al. has four infectious
Figure 5. Mechanistic model predicted human infectivity over
time and within a population. We calculated daily human infectivity
to mosquitoes, as a function of time post emergence, for 1,000
simulated individuals. (A) Asexual parasitemias from 1,000 model runs.
The wide diversity of host-parasite dynamics was fitted to malaria
therapy data. (B) The mean daily infectivity of 1,000 simulated
individuals for the first 300 days post emergence is shown as the red
curve, and the area between the 25th and 75th daily infectivity
percentiles is shown in blue. (C) Net infectivity for each of 1,000
individuals. The distribution of net human infectivity is represented as a
violin plot, which extends to the maximum infectivity. The red cross
illustrates the arithmetic mean infectiousness, and the green box shows
median infectiousness.
doi:10.1371/journal.pcbi.1003025.g005
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compartments varying in infectivity and clearance rate), and both
papers employ their models to predict the constant equilibrium
prevalence in untreated and treated cases.
We first compared the D(t) predicted from our model with those
from Lawpoolsri et al. [29] and Okell et al. [12]. Lawpoolsri et al.
assume that the mean rate of clearance in infectious individuals is
1/188 day21 with a constant daily human-to-mosquito infectious-
ness (c) of 0.5. In the model of Okell et al. [12], each of the four
infectious compartments in this model had different clearance
rates (1/10.5, 1/10.5, 1/31.5, 1/157.5 day21) and each compart-
ment had a different proportional infectivity (1.90, 3.08, 1.53,
0.28) of the average daily infectivity c= 0.05. We did not weight
these durations of infectivity for age or body surface area, i.e. we
calculated the unweighted D(t).
Figure 4 illustrates the cumulative distributions of the
durations of infection and infectiousness for these two models as
well that of the mechanistic model. We see that our mechanistic
model matches the malaria therapy curve closely compared to the
compartmental models. These latter models have significantly
heaver tails, indicating that individuals are infected for longer
periods of time in those models.
We can derive D(t) for the compartmental models [12,29], using
the curves from Figure 4A and the c values for each
compartment. Figure 6A shows D(t) for both of these models as
well as our mechanistic model; Figure 6B illustrates the first 200
days of this function for closer inspection. We see that the model of
Lawpoolsri et al. predicts that mean infectivity is above 5% for 433
days, the output from Okell et al. is above this threshold for only
45 days, and our mechanistic model output is above this value for
138 days (or until,153 days after emergence of parasites from the
liver, discounting the initial period when infectivity is near zero).
The differences in D(t) among the models may have to do with
model structure. Lawpoolsri et al. is constrained functionally by
the assumption of only one infectious compartment. Okell et al.
uses four infectious compartments and thus encompasses a much
larger class of distributions (the hypoexponential distributions) for
the lifetimes of infection. Further, by weighting the infectivity of
each of the duration of infectiousness compartments differently,
Okell et al. increase the degrees of freedom of D(t), allowing them
to more closely fit their target data. Further, these two models
differ in the data sets being fitted: the endemicity of the regions
being modeled at equilibrium in Lawpoolsri et al. are much lower
than those in Okell et al. It is possible that individuals in low-
endemicity areas are infectious at higher levels for longer periods
than individuals in high-endemicity areas, because acquired
immunity may limit the severity and density of repeated P.
falciparum infections. This effect may provide a means of identifying
the effects of immunity on transmission. However, we would need
to fit a variety of endemic equilibria with hypoexponential models
such as that of Okell et al. to test such a hypothesis. We cannot
generate quantitative conclusions from comparing the models of
Lawpoolsri et al and Okell et al directly, given their different
model structures.
Integrating over time, we find that the D values for these three
models are 7.2 fully infectious days for the model of Okell et al.,
,32 days using the current model, and 94 days in the model of
Lawpoolsri et al. We can also compare these values to an older
field-tested compartmental model, known as the ‘Garki model’
because it was fitted to data from a malaria-endemic site in Garki,
Nigeria [28]. This model includes compartments for immunity
such that immune individuals clear infections faster than non-
immune individuals.
To calculate the net human infectiousness D for this model, let
V0 be the vectorial capacity of an area. For malaria, V0:D~R0.
Further, let V be the critical vectorial capacity below which
transmission is unstable, i.e., V:D~1. Thus, D= 1/V. As derived
in the Garki model, V~
a1zd
g
, where a1 is the clearance rate of
infectivity, d is the death rate, and g is the probability of becoming




Using the values derived from Garki, we find that D= 45.5 fully
infectious days. For the Garki estimate, the values of a1 and d
were assumed and only g was fitted to data; thus essentially D
itself was fitted to data as a single parameter [28]. This fitted
Figure 6. Comparison of mean infectivity over time, D(t). The
mean human infectivity to mosquitoes was calculated as a function of
time for three models: our mechanistic model as well as the stochastic
representations of the models of Lawpoolsri et al. [29] and Okell et al.
[12]. For each model, the mean daily infectivity of 1,000 untreated
individuals was simulated. (A) Mean infectivity for the first 800 days for
the three models. (B) Mean infectivity for the first 200 days only. (C)
Infectivity curves for the three models, scaled so that mean infectivity is
equal to that of the mechanistic model.
doi:10.1371/journal.pcbi.1003025.g006
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value for D accords relatively well with the value generated by
our model [28].
Given our calculations of D, we can rescale the plots of D(t) by
multiplying each curve by a scaling factor so that models of
Lawpoolsri et al. and Okell et al. share the same mean net
infectivity as the mechanistic model; these results are shown in
Figure 6C. Once the models are rescaled, we can see more
clearly that the models of Okell et al. and the mechanistic model
predict that infectiousness is cleared at very similar rates
throughout the population, whereas Lawpoolsri et al. predict a
much more gradual loss of infectiousness. The closeness of D(t) for
the scaled stochastic representation of Okell et al. and the
mechanistic model is somewhat surprising, although Okell et al. do
parameterize some of their model parameters from malaria
therapy data.
Comparison of individual variability in human-to-
mosquito infectiousness among malaria models
In the previous section we calculated the mean responses of
individuals over time for the models of Lawpoolsri et al. [29] and
Okell et al. [12]. However, since these models are both
compartmental, they can readily be formulated as stochastic,
individual-based models by assuming that individuals are in each
infectious compartment for exponentially distributed times. We
thus computed the distribution of net infectiousness within a
population, Di, for both models. Figure 7 compares the
distributions Di for these two compartmental models to the
distribution generated by our mechanistic model. As implied by
the D(t) curves, Figure 7A illustrates that the model of Lawpoolsri
et al. predicts that some individuals have very high D values,
whereas the distribution Di generated by the model of Okell et al.
is much more centered about its mean. If we scale the distributions
Di to all have the same mean as the mechanistic model, we see that
Di for Lawpoolsri et al. is still much more dispersed than the
mechanistic model; however, Di for Okell et al. matches quite well
to that of the mechanistic model (Figure 7B).
Sensitivity analyses
We ran a variety of sensitivity analyses by varying the model
parameters and observing the changes in model output. For the
asexuals model, we adjusted Pm such that the mean duration of
infection varied between 183 and 237 days (,95% confidence
interval as reported by Sama et al. [59]). We found that the net
infectivity for the model varied from 29.9 to 37.4 net infectious
days, versus 32.4 for the best-fit parameters [1].
For the gametocyte model, we examined the effects of varying
the aG parameter. For our best-fit parameterization, we assumed
that aG,U(0.06, 1). If we assumed that aG followed the U(0, 1)
distribution, then the maximum average circulation time increased
to 24.0 days (close to the 22 recorded in malaria therapy; Table 3).
The average maximum circulation time was increased because the
lower bound of the uniform distribution was changed from 0.06 to
0.0, i.e., in some individuals gametocyte age had no effect on
gametocyte longevity. The average infectivity of the population
was increased by a small amount to 34.6 using the wider bounds
for aG, versus 32.4 for the model with aG,U(0.06, 1). Further, the
maximum number of net infectious days for aG,U(0, 1) was 181.5,
versus 125.2 for aG,U(0.06, 1). Thus, aG,U(0, 1) produced a very
heavy tail in the distribution of infectivity among individuals.
Regarding the relationship between gametocyte density and
human-to-mosquito infectivity, our default model outputs assumed
the relationship from Stepniewska et al. as fitted from malaria
therapy [48]. We also simulated the effects of assuming different
types of gametocyte density to infectivity relationships. Specifically,
we simulated 14 different types of possible functional relationships
between gametocyte densities and infectivity (Figure 3). Our
default assumption was called the ‘Median, Stage V’ relationship
(solid red line in Figure 3); we also assumed both ‘High’ and
‘Low’ Stage V relationships (illustrated as dashed red lines in
Figure 3). These latter relationships were chosen to capture much
of the observed variation in the Carter and Graves data [63,64].
Further, we ran a logistic regression through the Carter and
Graves data to develop another functional relationship (dark blue
line in Figure 3); this logit fit was similar to the data reported in the
meta-analysis of Bousema et al. [56]. Each of these four
relationships relates observable (Stage V) gametocytes to infectiv-
ity, and for each of these four relationships we could apply the
Jeffery-Eyles observation that gametocytes are not infectious at the
onset of gametocyte appearance [47] to generate a total of eight
density-to-infectivity relationships.
To develop the six other possible relationships between
gametocyte densities and infectivity, we utilized additional
information regarding the biology of P. falciparum. Not all
gametocytes that are observable are infectious; once gametocytes
enter the circulation, they still need a brief number of days to
mature further before becoming infectious [47,68,69]. Circulating
Stage V gametocytes can be further discriminated into two
categories: Stage VA gametocytes and Stage VB gametocytes [68].
Stage VA gametocytes are circulating but are not infectious; Stage
VB gametocytes are both circulating and infectious. Thus we
generated three additional functional relationships by assuming
Figure 7. Comparison of distributions of net human infectivity,
Di . The distributions of net human infectivity were calculated for three
models: our mechanistic model as well as the compartmental models of
Lawpoolsri et al. [29] and Okell et al. [12]. (A) The infectivity for each of
1,000 individuals was integrated over time for each model. The
distributions of net infectivity among individuals are represented as
violin plots (vertical histograms); the plots extend to the maximum
infectivity. (B) Scaled distributions of net infectivity. The distributions in
panel (A) were rescaled by multiplying by a scaling factor such that all
three distributions had the same mean as that of the mechanistic
model. The red crosses illustrate the arithmetic mean infectivity, while
the green boxes show the median infectivity.
doi:10.1371/journal.pcbi.1003025.g007
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that observable gametocytes were infectious only after two
additional days of maturation. These three relationships were
designed to parallel the ‘Median,’ ‘High,’ and ‘Low’ relationships
from above but assuming only Stage VB gametocytes are
infectious; these are illustrated in light blue in Figure 3. We then
modified each of the three Stage VB assumptions by assuming that
there is a short period at the beginning of infections in which
gametocytes are not infectious, as above [47], for a total of 14
possible functional relationships between gametocyte density and
infectivity.
The mean net infectivity values for seven of the parameteriza-
tions are 70.0, 41.1, 23.6, 64.1, 33.3, 16.2, and 36.3 net infectious
days for the Stage VB, High; Stage VB, Median; Stage VB, Low;
Stage V, High; Stage V, Median; Stage V, Low; and Carter &
Graves parameterizations, respectively (without the Jeffery-Eyles
corrections and with mintrans= 0). If we include the effects of the
Jeffery-Eyles correction, these seven parameterizations yield 68.2,
40.2, 23.1, 61.2, 32.0, 15.6, and 35.0 mean net infectious days,
respectively (assuming mintrans= 0). Each mean is from 1,000 runs.
Varying the assumed relationship between gametocyte density and
infectivity will also affect other aspects of transmission by altering
the duration between parasite emergence and infectivity and/or
the total duration of positive infectivity.
Also of note, our model calculated P. falciparum infection
dynamics only among adults, as there are no malaria therapy data
for children and it is not well-understood how children differ in
their overall levels of infectivity from adults. In a companion paper
(Johnston et al., in prep) we discuss how our results concerning
infectivity among adults may translate to children and the
implications of using our model results for malaria control
planning.
Discussion
Here we describe the development of a novel, stochastic, within-
host model of the progression of malaria in patients with no
acquired malarial immunity. This model utilizes the difference
equations originally developed by Molineaux and Dietz to
simulate the progression of asexual and sexual parasitemias [23–
25]. We have parameterized these equations so that the entire
range of observed responses in malaria therapy can be reproduced
without needing to fit parameters to individual case histories. We
also extended the modeling framework from [23–25] to include
components for simulating the onset of first fever and human-to-
mosquito transmission.
Once our mechanistic model was formulated, we revisited the
analytic Ross-Macdonald model to examine how human infec-
tiousness enters into the formula for the basic reproduction
number R0. We then analyzed human infectiousness in three ways,
calculating the mean human infectivity over time D(t), the
distribution of net infectivity Di, and the mean net human
infectivity, D. We found that D in our mechanistic model is
approximately 32 fully infectious days. This quantity is invariant in
a population over time and plays a crucial role in determining R0.
We have utilized this value in recent malaria mapping work [1],
although a full mathematical treatment of this quantity was left
until the present.
Our study included a review of the mathematical literature to
determine whether we could impute these quantities from other
modeling work to provide a baseline for comparison. We
examined the models of Lawpoolsri et al. [29], Okell et al. [12],
and the Garki model [28], and found them to vary widely in their
calculation of D, D(t) and Di. We propose that our new estimate of
D is the most appropriate one for R0, because R0 assumes no
acquired immunity and our model is parameterized solely from
malaria therapy studies with individuals that were non-immune.
The other models cannot easily disentangle the effects of acquired
immunity, multiplicity of infection, and control efforts from the
effects of immunity acting on a single infection, though we have
described how future efforts might begin to separate these
quantities.
In addition to our calculation of the invariant D and its
importance for R0, we also predict that human infectiousness
persists for a long period of time at levels sufficient to promote
transmission in areas of high vectorial capacity. While these
calculations are for populations with no acquired immunity, they
are relevant for malaria elimination efforts because antimalarial
immunity wanes rapidly in the absence of infection [17,70]. As this
immunity wanes, the responses of individuals to infection can be
expected to approach those observed in malaria-naı¨ve individuals
[28,66]. Of note, a recent study in Senegal found that persistent
infectiousness prevented interruption of transmission even when
incidence had been reduced to very low levels through insecticide-
treated bed nets and usage of ACTs [17]. Our model confirms the
relevance of persistent low-level infectiousness for elimination
efforts.
In addition to the usefulness of these results for mapping and
control efforts, the modeling platform and analytic framework
described herein will help clarify the different assumptions among
malaria models. Further, because we calculate asexual and sexual
parasite densities daily, and because the model reproduces the
entire variability of host-parasite dynamics observed in malaria
therapy, our modeling framework provides a powerful new tool for
exploring the effects of antimalarial treatments on transmission. As
malaria decreases worldwide, our model results will become more
relevant to more regions of the world, thus helping to improve
targeting of control efforts.
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